Kesselheim AS, Tu SS - US Court of Appeals for the Ninth Circuit
xAI mischaracterizes Ruckelshaus v. Monsanto by treating it as establishing a per se taking whenever a government requires disclosure of trade secret information, as California’s AI training data transparency law does, when in fact Monsanto requires a governmental promise of secrecy, absent from the state’s law, for any such takings claim to succeed. The amici warn that accepting xAI’s broad interpretation would let companies challenge transparency mandates as unconstitutional takings across other domains, chilling state regulation of AI as well as disclosure requirements covering drug prices, hazardous chemical spills, and cosmetics ingredients.
VIEW SOURCE
Costa E, Kesselheim AS - Journal of Law, Medicine, & Ethics
Kirby-Rivera L, Feldman WB, Kim M, Kosmopoulou G, Kesselheim AS, Tu SS - Journal of Law, Medicine, & Ethics
Eisenkraft Klein D, Kesselheim AS - Health Policy